loading page

Novel RNAVaccine Report: A Case Report of COVID-19 MRNA Vaccine Induced Immune Thrombocytopenic Purpura
  • +2
  • Oladipo Cole,
  • Vinodhini Arjunan,
  • Zackary Franzen,
  • Sarah Rabinowitz,
  • Nabil Benhayoun
Oladipo Cole
Florida Atlantic University
Author Profile
Vinodhini Arjunan
Florida Atlantic University
Author Profile
Zackary Franzen
Florida Atlantic University
Author Profile
Sarah Rabinowitz
Florida Atlantic University
Author Profile
Nabil Benhayoun
Florida Atlantic University
Author Profile

Abstract

We describe a 74-year-old female who presented with thrombocytopenia 20 days after receiving her first dose of the novel mRNA vaccine. After an exhaustive workup, Immune Thrombocytopenia was diagnosed secondary to her recent mRNA vaccine administration. She was treated aggressively with high-dose steroids and IVIG, with adequate response.

Peer review status:IN REVISION

26 Jun 2021Submitted to Clinical Case Reports
10 Jul 2021Assigned to Editor
10 Jul 2021Submission Checks Completed
11 Jul 2021Reviewer(s) Assigned
22 Jul 2021Review(s) Completed, Editorial Evaluation Pending
29 Jul 2021Editorial Decision: Revise Minor